Many drugs are aimed at enhancing the therapeutic potential of nitric oxide (NO) in the cardiovascular system. However these generally lack selectivity and hence there is a need to treat diseased tissues more specifically in order to restore their function.
This can be achieved by boosting the natural enzymatic synthesis of NO, which is impaired in pulmonary hypertension, atherosclerosis and diabetes. Supplementation of the natural cofactor of the enzyme (tetrahydrobiopterin) has clinical efficacy, but the compound must be injected.
Researchers at the University of Strathclyde have created small novel analogues of the cofactor tetrahydrobiopterin. The new analogues can selectively enhance NO activity in damaged blood vessels more effectively than the natural substance. By enhancing the NO activity, the enzymatic activity is restored, thus preventing progression of the disease.
Scotland's Universities produce world leading research and intellectual property.
Tuesday, 31 January 2012
Thursday, 19 January 2012
Solar Windows creating energy...
The ambition to include energy generation into buildings is growing as we become increasingly concerned with energy costs and climate change.
With this is mind it is clear that "Building Integrated Applied" or "Building Applied Photo-Voltaic" (BIPV or BAPV) energy generation is becoming increasingly common in new builds or as a retrofit upgrade to homes, offices etc. Many of these PV systems use either an array of fixed solar concentrators or an active solar tracking system to maximise light capture as the sun moves across the sky.
The PV material of the solar Cells is often a Silicon material, however this is opaque to visible light and severely limits the light transmission property of the the solar panel making it unsuitable for direct use as a window or skylight in a roof. But now scientists at the Scottish Institute for Solar Energy Research (SISER) have developed a new design of solar concentrator offering both energy generation and light transmission properties.
This opens up the fascinating possibility of a window generating energy - think about that the next time your window cleaner calls with his bucket and ladder.
With this is mind it is clear that "Building Integrated Applied" or "Building Applied Photo-Voltaic" (BIPV or BAPV) energy generation is becoming increasingly common in new builds or as a retrofit upgrade to homes, offices etc. Many of these PV systems use either an array of fixed solar concentrators or an active solar tracking system to maximise light capture as the sun moves across the sky.
The PV material of the solar Cells is often a Silicon material, however this is opaque to visible light and severely limits the light transmission property of the the solar panel making it unsuitable for direct use as a window or skylight in a roof. But now scientists at the Scottish Institute for Solar Energy Research (SISER) have developed a new design of solar concentrator offering both energy generation and light transmission properties.
This opens up the fascinating possibility of a window generating energy - think about that the next time your window cleaner calls with his bucket and ladder.
Wednesday, 18 January 2012
Sedatives and valerian plants...
The medicinal properties of valerian plants has been know since the time of the ancient Greeks, especially the sedative powers. But the preparations of plant materials are variable in composition and in effectiveness.
Surprisingly despite it's longevity the active components have not been identified. Some isolated components, such as valepotriates, baldrinals and valerenic acid have been studied, but their sedative activity does not explain the potency of the original extracts. The overall effect of the extract is widely assumed to result from synergistic actions of several components, although this has never been demonstrated.
Now researchers at the University of Strathclyde have identified highly active fractions from valerian extracts that contain novel, previously unidentified active molecules. These novel molecules act synergistically to prolong sleeping times. In addition, by isolating the molecules it has been discovered that novel combination products with reduced propensity for side effects can be achieved.
It looks like we are finally starting to find out how the properties of the plant actually work - I'm sure the ancient Greeks would be impressed.
Surprisingly despite it's longevity the active components have not been identified. Some isolated components, such as valepotriates, baldrinals and valerenic acid have been studied, but their sedative activity does not explain the potency of the original extracts. The overall effect of the extract is widely assumed to result from synergistic actions of several components, although this has never been demonstrated.
Now researchers at the University of Strathclyde have identified highly active fractions from valerian extracts that contain novel, previously unidentified active molecules. These novel molecules act synergistically to prolong sleeping times. In addition, by isolating the molecules it has been discovered that novel combination products with reduced propensity for side effects can be achieved.
It looks like we are finally starting to find out how the properties of the plant actually work - I'm sure the ancient Greeks would be impressed.
Marigolds and the treatment of Psoriasis...
Many of us are familiar with the appearance of Psoriasis due to the Denis Potter play "The Singing Detective".
The skin disease is characterised by inflammation and scaly lesions of the skin and affects around 2% of the population in Europe and North America. Although several different therapies are currently being used to treat psoriasis, but they all have the possibility of serious side effects. They are also expensive to produce and lack efficacy in some patients.
Researchers at the University of Strathclyde have isolated a novel compound for the treatment of psoriasis from a plant extract of Calendula officinalis (Marigold). The compound has anti-proliferative effects against normal skin cells growing in tissue culture and has cleared initial regulatory toxicology testing. The compound can be applied locally to affected areas of the skin, thereby minimising the chances of systemic side effects.
Who would have thought that something as pretty as a Marigold could have such powerful properties. Sounds like something to sing about.
The skin disease is characterised by inflammation and scaly lesions of the skin and affects around 2% of the population in Europe and North America. Although several different therapies are currently being used to treat psoriasis, but they all have the possibility of serious side effects. They are also expensive to produce and lack efficacy in some patients.
Researchers at the University of Strathclyde have isolated a novel compound for the treatment of psoriasis from a plant extract of Calendula officinalis (Marigold). The compound has anti-proliferative effects against normal skin cells growing in tissue culture and has cleared initial regulatory toxicology testing. The compound can be applied locally to affected areas of the skin, thereby minimising the chances of systemic side effects.
Who would have thought that something as pretty as a Marigold could have such powerful properties. Sounds like something to sing about.
Anti-Inflammatory Agents...
With an ageing population addressing conditions such as arthritis becomes more and more important.
Chronic inflammation doesn't just impact those with arthritis however and contributes to a broad spectrum of diseases including arthritis, psoriasis, diabetes, allergy, connective tissue diseases, and heart disease. Researchers felt that despite the range of current therapeutics on offer, there was an unmet clinical need as treatments such as corticosteroids, though often effective, are associated with serious side effects.
A research team at the Universities of Strathclyde and Glasgow have taken the novel approach of searching for anti-inflammatory agents produced by pathogens during their battle to avoid elimination by the host.
This novel approach has led to their discovery of ES-62, a glycoprotein that is secreted by filarial nematodes, highly successful parasites of vertebrates including humans. The team has demonstrated that ES-62 is a potent, broad spectrum anti-inflammatory molecule which effectively reduces inflammation whilst leaving essential defence mechanisms intact.
The work is more than just promising with further research able to produce small molecule derivatives (SMDs) that exhibit anti-inflammatory activity in vivo.
Chronic inflammation doesn't just impact those with arthritis however and contributes to a broad spectrum of diseases including arthritis, psoriasis, diabetes, allergy, connective tissue diseases, and heart disease. Researchers felt that despite the range of current therapeutics on offer, there was an unmet clinical need as treatments such as corticosteroids, though often effective, are associated with serious side effects.
A research team at the Universities of Strathclyde and Glasgow have taken the novel approach of searching for anti-inflammatory agents produced by pathogens during their battle to avoid elimination by the host.
This novel approach has led to their discovery of ES-62, a glycoprotein that is secreted by filarial nematodes, highly successful parasites of vertebrates including humans. The team has demonstrated that ES-62 is a potent, broad spectrum anti-inflammatory molecule which effectively reduces inflammation whilst leaving essential defence mechanisms intact.
The work is more than just promising with further research able to produce small molecule derivatives (SMDs) that exhibit anti-inflammatory activity in vivo.
Drug delivery for cancer...
Effective drug delivery has long been a problem for clinicians but now researchers at the University of Strathclyde have pioneered a technique which delivers drugs through the use of a proprietary delivery system that could improve matters significantly.
There are a number of impediments to effective drug delivery, these can include erroneous absorption reducing the concentration of the drug at the target site. In order to overcome this, a technique has been pioneered which delivers drugs through the use of microscopic shipping vessels which act as transporters of the entrapped drug and preferentially target it to phagocytic cells within a tissue.
Administration of these drug loaded particles by inhalation allows non-invasive drug delivery to be realised, minimising repeat administrations due to increased efficacy. The breakthrough is seen as a platform technology which can be used for a number of applications in the treatment of lung conditions such as infectious diseases, cancer and asthma.
There are a number of impediments to effective drug delivery, these can include erroneous absorption reducing the concentration of the drug at the target site. In order to overcome this, a technique has been pioneered which delivers drugs through the use of microscopic shipping vessels which act as transporters of the entrapped drug and preferentially target it to phagocytic cells within a tissue.
Administration of these drug loaded particles by inhalation allows non-invasive drug delivery to be realised, minimising repeat administrations due to increased efficacy. The breakthrough is seen as a platform technology which can be used for a number of applications in the treatment of lung conditions such as infectious diseases, cancer and asthma.
Drug-Eluting Stent for diabetic patients...
Stent implantation is now a common and highly effective treatment for restoring blood flow through an artery; however the re-narrowing of the diseased artery can occur in a significant proportion of patients.
Although drug-eluting stents have been developed to limit this re-narrowing they have limited effectiveness in diabetic patients. In addition, the drugs that are used inhibit regrowth of the endothelium which is required to protect the artery. Clearly then there is a need for an improved drug-eluting stent that will be suitable for diabetic patients and which will not harm the endothelium.
Using an in vivo model, researchers at the University of Strathclyde have found that restenosis can be prevented by a novel, proprietary compound with no harmful effects on endothelial properties. VAN 10-4, a novel small molecule, exerts a marked protection against the development of restenosis when applied as a drug-eluting stent or given as a short-term local infusion.The researchers believe that the use of VAN 10-4 on a drug-eluting stent holds great promise as a superior stent for high risk patients. Good news for those with diabetes and many others.
Although drug-eluting stents have been developed to limit this re-narrowing they have limited effectiveness in diabetic patients. In addition, the drugs that are used inhibit regrowth of the endothelium which is required to protect the artery. Clearly then there is a need for an improved drug-eluting stent that will be suitable for diabetic patients and which will not harm the endothelium.
Using an in vivo model, researchers at the University of Strathclyde have found that restenosis can be prevented by a novel, proprietary compound with no harmful effects on endothelial properties. VAN 10-4, a novel small molecule, exerts a marked protection against the development of restenosis when applied as a drug-eluting stent or given as a short-term local infusion.The researchers believe that the use of VAN 10-4 on a drug-eluting stent holds great promise as a superior stent for high risk patients. Good news for those with diabetes and many others.
Animal free tissue culture media...
The need for tissue culture media has never been greater given the recent explosion in molecular biology. Addressing that need is the ground breaking research from the University of Strathclyde where they have produced a synthetic low density lipoprotein (sLDL). The key is in the word "synthetic" ensuring it can be prepared from animal-free ingredients while providing all the required lipids in one product.
Tissue culture media is usually supplemented with foetal calf serum which provides essential lipids to maintain cell viability and promote growth. However this is expensive and suffers from inherent biological variability, potential contamination from adventitious agents and increased regulatory scrutiny. These issues have led to the drive for animal component-free media and now Strathclyde have the answer.
The synthetic low density lipoprotein (sLDL) circumvents the problems associated with serum, and its constituents can be more accurately controlled. Unlike current artificial lipid supplements, sLDL also provides the cells with lipids in the correct biological format for natural assimilation via the LDL pathway.
With the increase in molecular biology developments set to continue looks like the Strathclyde researchers are onto a winner.
Tissue culture media is usually supplemented with foetal calf serum which provides essential lipids to maintain cell viability and promote growth. However this is expensive and suffers from inherent biological variability, potential contamination from adventitious agents and increased regulatory scrutiny. These issues have led to the drive for animal component-free media and now Strathclyde have the answer.
The synthetic low density lipoprotein (sLDL) circumvents the problems associated with serum, and its constituents can be more accurately controlled. Unlike current artificial lipid supplements, sLDL also provides the cells with lipids in the correct biological format for natural assimilation via the LDL pathway.
With the increase in molecular biology developments set to continue looks like the Strathclyde researchers are onto a winner.
Oil and Gas recovery using Plasma Channel Drilling...
It's no secret that the oil and gas industry is under constant pressure to find new ways of extracting the precious resources that we all rely on.
The University of Strathclyde’s Department of Electronic and Electrical Engineering have developed a new micro-hole drilling technique that could have significant benefits to the Oil & Gas, Mining, Water & Construction industries.
Lowering costs and maximising production is a continual driver in the industry and it has been estimated by that as much as 1.3 billion barrels of oil could be retrieved from existing wells in the North Sea if new recovery techniques become available.
This new Plasma Channel Drilling technique uses high voltage pulsed power to produce plasma-channel formation inside the rock or seabed. The extremely rapid expansion of the plasma channel within the rock causes it to fracture and fragment. The technology is designed to allow the drilling of slim holes and does not require any mechanical rotation of the drill shank.
The University of Strathclyde’s Department of Electronic and Electrical Engineering have developed a new micro-hole drilling technique that could have significant benefits to the Oil & Gas, Mining, Water & Construction industries.
Lowering costs and maximising production is a continual driver in the industry and it has been estimated by that as much as 1.3 billion barrels of oil could be retrieved from existing wells in the North Sea if new recovery techniques become available.
This new Plasma Channel Drilling technique uses high voltage pulsed power to produce plasma-channel formation inside the rock or seabed. The extremely rapid expansion of the plasma channel within the rock causes it to fracture and fragment. The technology is designed to allow the drilling of slim holes and does not require any mechanical rotation of the drill shank.
Detecting the freshness of sealed food...
Have you ever wondered how you can detect if food is still fresh within its sealed packaging?
Modified Atmosphere Packaging (MAP) is a modern and much used method to protect oxygen sensitive items, most commonly foodstuffs and sterilised medical equipment. It is imperative within this form of packaging that the level of oxygen is known, to indicate product tampering and assure quality.
Current oxygen sensors tend to be unreliable, due to their reversibility with oxygen, and are also typically costly with short shelf-lives.
The good news is that new research from researchers at The University of Strathclyde have discovered a novel sensor for measuring oxygen levels within MAP. Critically, the sensor changes colour on the detection of oxygen. This ensures that staff within supermarkets and similar businesses can quickly and easily monitor product quality.
All that is required is that the sensor is 'activated' using UV light - clever stuff from Strathclyde.
Modified Atmosphere Packaging (MAP) is a modern and much used method to protect oxygen sensitive items, most commonly foodstuffs and sterilised medical equipment. It is imperative within this form of packaging that the level of oxygen is known, to indicate product tampering and assure quality.
Current oxygen sensors tend to be unreliable, due to their reversibility with oxygen, and are also typically costly with short shelf-lives.
The good news is that new research from researchers at The University of Strathclyde have discovered a novel sensor for measuring oxygen levels within MAP. Critically, the sensor changes colour on the detection of oxygen. This ensures that staff within supermarkets and similar businesses can quickly and easily monitor product quality.
All that is required is that the sensor is 'activated' using UV light - clever stuff from Strathclyde.
Friday, 13 January 2012
Research in malaria vaccine...
An innovation in vaccine development has emerged from researchers at The University of Edinburgh which could well help in the fight against Malaria.
The Edinburgh based researchers have developed a synthetic vaccine that incorporates the highly variable repeat sequences of the merozoite surface protein antigen from Plasmodium falciparum.
Plasmodium falciparum is transmitted to human beings through the bite of the female Anopheles mosquito and is the most common cause of human malaria. It's extensive polymorphism nature has been a complex challenge for vaccine design, however, there is significant experimental evidence to suggest that polymorphic regions of the parasite play a role in natural immunity.
Now, however, Edinburgh's researchers have designed a novel synthetic hybrid sequence, incorporating all the known immunogenic antibody epitopes for each of the K1 and MAD20 polymorphic Block 2 regions. Pre-clinical animal trials are looking extremely promising.
The Edinburgh based researchers have developed a synthetic vaccine that incorporates the highly variable repeat sequences of the merozoite surface protein antigen from Plasmodium falciparum.
Plasmodium falciparum is transmitted to human beings through the bite of the female Anopheles mosquito and is the most common cause of human malaria. It's extensive polymorphism nature has been a complex challenge for vaccine design, however, there is significant experimental evidence to suggest that polymorphic regions of the parasite play a role in natural immunity.
Now, however, Edinburgh's researchers have designed a novel synthetic hybrid sequence, incorporating all the known immunogenic antibody epitopes for each of the K1 and MAD20 polymorphic Block 2 regions. Pre-clinical animal trials are looking extremely promising.
Thursday, 12 January 2012
Protease inhibitor with therapeutic potential...
Dundee University researches have been busy researching Protease inhibitors and have recently filed patent on their last research. Protease inhibitors are agents that can stop splitting a protein into peptides and are used primarily in HIV/AIDS treatment.
The Dundee researchers state "Based on their importance in health and disease, the proteases of the endo-lysosomal pathway - particularly the cathepsins - have frequently been proposed as therapeutic targets. Effective pharmaceutical exploitation of the pathway has been prevented by the issue of redundancy - novel methods to overcome this challenge are required."
The Dundee researchers state "Based on their importance in health and disease, the proteases of the endo-lysosomal pathway - particularly the cathepsins - have frequently been proposed as therapeutic targets. Effective pharmaceutical exploitation of the pathway has been prevented by the issue of redundancy - novel methods to overcome this challenge are required."
Subscribe to:
Posts (Atom)